Stephen Horrigan

Stephen Horrigan has extensive work experience in the field of research and scientific leadership. Stephen began their career in 2000 as the Vice President of Research at Avalon Pharmaceuticals, where they worked until 2009. From there, they joined PGxHealth as the Vice President of Research until 2010. In 2010, they became the Chief Scientific Officer at Noble Life Sciences Inc and held that position until 2011. Stephen then moved to Iterion Therapeutics, where they currently serve as the Chief Scientific Officer.

Stephen Horrigan completed their education at Syracuse University, where they earned a Bachelor of Science degree in Biology from 1979 to 1985. Stephen then pursued further studies at the same institution and obtained a Ph.D. in Biology from 1985 to 1990.